HIVE Stock Draws Fresh Buy Rating On AI And Bitcoin Push

HIVE Digital Technologies Ltd stocks have been trading up by 6.2 percent amid upbeat sentiment around cryptocurrency and AI infrastructure gains.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading HIVE

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Chardan initiated coverage of Hive Digital with a Buy rating and a $7.50 price target, highlighting upside from its bitcoin mining scale and rapid expansion into AI-focused GPU cloud and colocation services, particularly targeting the Canadian sovereign AI market.
A new Buy rating from Chardan, with a $7.50 target, adds fresh bullish coverage on HIVE Digital Technologies Ltd.
Chardan’s $7.50 target sits above the current $7.06 analyst mean, reinforcing an overall Buy consensus on HIVE and signaling Street confidence despite volatility in crypto-related names.

Quick Financial Overview

HIVE Digital Technologies Ltd is trading in the low $2s, with the most recent close around $2.69 after a steady intraday grind higher from the mid‑$2.50s. On the daily chart, HIVE has faded from the $3.10 area over the last few weeks, but price has started to stabilize between $2.60 and $2.90, creating a tight trading range that short‑term traders watch for breakouts.

Under the hood, HIVE’s financials show a classic high‑beta, high‑risk growth profile. Revenue over the last year came in near $298M, with revenue growth over three years above 250%, but margins are deep in the red. HIVE posted a quarterly net loss of about $145M for the period ending 2026/03/31, and EBIT margin sits near ‑48%. That tells traders the core bitcoin and infrastructure operations are not yet producing consistent profits.

More Breaking News

Balance sheet strength is the offset. HIVE reports roughly $639M in assets, modest total liabilities of about $110M, and a low total‑debt‑to‑equity ratio near 0.11. With a price‑to‑sales ratio around 1.7 and price‑to‑book near 1.4, traders are paying a relatively low multiple for a volatile crypto and AI infrastructure story.

Why Traders Are Watching HIVE’s New Analyst Coverage

HIVE Digital Technologies just picked up a key catalyst: Chardan initiated coverage with a Buy rating and a $7.50 price target. For a stock trading under $3, that target implies meaningful upside in the eyes of the Street. Traders do not ignore a fresh initiation like this, especially on a name tied to both bitcoin and AI infrastructure.

The core of Chardan’s thesis is that HIVE is no longer just a straight bitcoin miner. The firm highlighted HIVE’s bitcoin mining scale plus its rapid move into AI‑focused GPU cloud and colocation services. That shift matters. It gives HIVE exposure to two hot themes—crypto and AI compute—rather than leaving the business fully at the mercy of bitcoin’s next halving or macro cycle.

Chardan also called out HIVE’s push to serve the Canadian sovereign AI market. That phrase tells traders something important: HIVE is targeting long‑term, potentially sticky customers like government and public‑sector AI workloads, not only chasing retail hash‑power hype. If those contracts build over time, they can smooth out the violent swings that usually dominate crypto‑linked names.

Another piece of context: Chardan’s $7.50 target sits slightly above the current analyst mean target of $7.06, reinforcing the overall Buy consensus on HIVE. When a new firm steps in above the existing average, it often signals growing confidence rather than late‑cycle cheerleading. For active traders, that can help fuel momentum when price starts to break over recent resistance levels on the chart.

Conclusion

Put it all together, and HIVE Digital Technologies sits at the intersection of big themes and big risk. The chart shows a stock trying to base in the mid‑$2 range after a pullback from the low $3s. The fundamentals show heavy losses but rapid revenue growth, a relatively clean balance sheet, and real assets tied to bitcoin mining and GPU infrastructure. Now layer in Chardan’s new Buy rating and $7.50 price target, above the $7.06 analyst mean, and you have a clear, tradable narrative.

For traders, HIVE is a classic “story stock.” The story is that HIVE is transforming from a pure crypto miner into a dual‑engine business: bitcoin plus AI‑driven GPU cloud and colocation, with a specific angle on Canadian sovereign AI demand. If that story keeps gaining traction on the Street, upgrades and initiations like Chardan’s can act as gasoline on any technical breakout.

None of this removes the risk. HIVE still shows negative margins, high earnings volatility, and a share price that moves with both bitcoin and AI sentiment. That is why traders in the Tim Sykes community focus on price action, catalysts, and strict risk control rather than blind belief. As Tim Sykes likes to remind traders, “Patterns repeat, but you have to manage your risk every single time.” As Tim Bohen, lead trainer with StocksToTrade says, “The best way to learn is by tracking trades, wins, losses, and lessons learned. Every trade has something to teach.”. HIVE gives you the pattern and the catalyst; your job is to trade the plan, not the hype.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!